Virtus ETF Advisers’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,676
| Closed | -$83.4K | – | 385 |
|
|
2025
Q1 | $83.4K | Buy |
+24,676
| New | +$83.4K | 0.11% | 165 |
|
|
2021
Q2 | – | Sell |
-35,712
| Closed | -$168K | – | 403 |
|
|
2021
Q1 | $168K | Buy |
35,712
+633
| +2% | +$2.98K | 0.07% | 343 |
|
|
2020
Q4 | $251K | Buy |
35,079
+9,668
| +38% | +$69.2K | 0.1% | 313 |
|
|
2020
Q3 | $271K | Sell |
25,411
-3,463
| -12% | -$36.9K | 0.14% | 247 |
|
|
2020
Q2 | $364K | Buy |
28,874
+2,166
| +8% | +$27.3K | 0.17% | 248 |
|
|
2020
Q1 | $244K | Sell |
26,708
-3,900
| -13% | -$35.6K | 0.1% | 256 |
|
|
2019
Q4 | $427K | Buy |
30,608
+20,178
| +193% | +$281K | 0.07% | 237 |
|
|
2019
Q3 | $180K | Sell |
10,430
-581
| -5% | -$10K | 0.04% | 265 |
|
|
2019
Q2 | $300K | Sell |
11,011
-14,640
| -57% | -$399K | 0.06% | 214 |
|
|
2019
Q1 | $491K | Sell |
25,651
-3,556
| -12% | -$68.1K | 1.04% | 30 |
|
|
2018
Q4 | $275K | Buy |
29,207
+7,338
| +34% | +$69.1K | 0.05% | 139 |
|
|
2018
Q3 | $414K | Sell |
21,869
-15,633
| -42% | -$296K | 0.04% | 152 |
|
|
2018
Q2 | $733K | Sell |
37,502
-15,905
| -30% | -$311K | 0.65% | 81 |
|
|
2018
Q1 | $1M | Buy |
53,407
+29,821
| +126% | +$561K | 0.87% | 40 |
|
|
2017
Q4 | $392K | Buy |
+23,586
| New | +$392K | 0.49% | 58 |
|